GL1X · GenesisL1 explorer

Research workbench

Hybrid designing of potent inhibitors of striga strigolactone receptor SHHTL7

Analyse Hybrid designing of potent inhibitors of striga strigolactone receptor SHHTL7 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7C8L
Type
protein
Length
268 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hyposensitive to light 7
UniProt
A0A0M3PNA2
Ligands
EGC, FP6, SO4
Pockets
1 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHyposensitive to light 7protein26847% helix, 18% strandA0A0M3PNA2

Ligands and binding sites

  • EGC · 2-(2-{2-[2-(2-{2-[2-(2-{2-[4-(1,1,3,3-tetramethyl-butyl)-phenoxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethanol · ligand · chains A
  • FP6 · pyrrolidine-1-carbaldehyde · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13060.780.8935EGC, FP6

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7C8L · Hybrid designing of potent inhibitors of Striga strigolactone receptor ShHTL7 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.